Related Experiment Video
Updated: Oct 14, 2025

A Reproducible Cartilage Impact Model to Generate Post-Traumatic Osteoarthritis in the Rabbit
Published on: November 21, 2023
G Protein-Coupled Receptors in Osteoarthritis: A Novel Perspective on Pathogenesis and Treatment
Ze-Qin Wen1,2, Di Liu1, Yi Zhang1,3
1Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.
Abstract:
G protein-coupled receptors (GPCRs) are transmembrane receptor proteins that trigger numerous intracellular signaling pathways in response to the extracellular stimuli. The GPCRs superfamily contains enormous structural and functional diversity and mediates extensive biological processes. Until now, critical roles have been established in many diseases, including osteoarthritis (OA). Existing studies have shown that GPCRs play an important role in some OA-related pathogenesis, such as cartilage matrix degradation, synovitis, subchondral bone remodeling, and osteophyte formation. However, current pharmacological treatments are mostly symptomatic and there is a paucity of disease-modifying OA drugs so far. Targeting GPCRs is capable of inhibiting cartilage matrix degradation and synovitis and up-regulating cartilage matrix synthesis, providing a new therapeutic strategy for OA. In this review, we have comprehensively summarized the structures, biofunctions, and the novel roles of GPCRs in the pathogenesis and treatment of OA, which is expected to lay the foundation for the development of novel therapeutics against OA. Even though targeting GPCRs may ameliorate OA progression, many GPCRs-related therapeutic strategies are still in the pre-clinical stage and require further investigation.
Insights
G protein-coupled receptors (GPCRs) are key in osteoarthritis (OA) pathogenesis. Targeting GPCRs offers a promising therapeutic strategy to modify OA progression and improve cartilage health.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are diverse transmembrane proteins mediating cellular responses.
- GPCRs are implicated in osteoarthritis (OA) pathogenesis, influencing cartilage degradation, inflammation, and bone remodeling.
- Current OA treatments are largely symptomatic, lacking disease-modifying capabilities.
Purpose of the Study:
- To comprehensively review the structure, biofunctions, and roles of GPCRs in OA pathogenesis.
- To explore GPCRs as a therapeutic target for novel OA treatments.
- To provide a foundation for developing new OA therapeutics targeting GPCRs.
Main Methods:
- Literature review of existing studies on GPCRs and osteoarthritis.
- Analysis of GPCRs' involvement in OA-related biological processes.
- Evaluation of GPCR-targeting strategies for OA treatment.
Main Results:
- GPCRs play critical roles in cartilage matrix degradation, synovitis, subchondral bone remodeling, and osteophyte formation in OA.
- Targeting GPCRs can inhibit OA-related degradation and inflammation while promoting cartilage synthesis.
- GPCR-targeted therapies show potential for disease modification in OA.
Conclusions:
- GPCRs represent a significant therapeutic target for osteoarthritis.
- Modulating GPCRs offers a novel strategy to address OA pathogenesis and progression.
- Further research is needed as many GPCR-targeted strategies are in early pre-clinical stages.
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
The JAK-STAT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Activation and Inactivation of G Proteins

